相关实验视频
Updated: Jul 23, 2025

12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
18.9K
一个药剂师主导的实践,以改善外科手术期间的血糖控制在选择性外科手术
1Alberta Health Services, Calgary, Alberta, Canada.
概括
这项研究强调了在接受手术的糖尿病患者中管理高血糖症的最佳实践. 它详细介绍了及时识别和治疗的策略,改善了糖尿病患者的外科治疗结果.
科学领域:
- 内分泌学 在内分泌学.
- 手术护理 手术护理
- 提高质量 提高质量
背景情况:
- 糖尿病管理对于手术患者至关重要.
- 高血糖症在选择性手术期间和之后存在风险.
- 需要有效的术前和术后方案.
研究的目的:
- 描述一项旨在及时识别和治疗高血糖症的倡议.
- 为了改善接受选择性手术的糖尿病患者的护理.
- 在手术背景下分享糖尿病管理的最佳实践.
主要方法:
- 实施一种标准化的血糖监测协议.
- 促进迅速调整胰岛素治疗.
- 手术和内分泌学团队之间的多学科合作.
主要成果:
- 改善了手术前后高血糖的识别率.
- 及时启动适当的治疗.
- 提高对血糖目标的坚持.
结论:
- 描述的努力成功地促进了及时的高血糖管理.
- 标准化的协议和协作是改善糖尿病患者手术结果的关键.
- 这一举措是改善手术期间糖尿病护理质量的典范.
相关概念视频
Peripheral Artery Disease V: Postoperative Nursing Management
12
During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
12
Diabetes: Management and Pharmacotherapy
319
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
319
Hypoglycemia and Glucagon
305
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
305
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
208
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...
Acarbose and miglitol are...
208
Endoscopic Procedures IV: Sigmoidoscopy and Laproscopy
119
Sigmoidoscopy and laparoscopy are distinct medical procedures that enable physicians to internally inspect different parts of the GI tract. Although they serve different purposes, each is essential for diagnosing and, in some cases, treating various medical conditions.
Sigmoidoscopy
Sigmoidoscopy is a diagnostic procedure that uses a flexible sigmoidoscope equipped with a light source and camera to examine the rectum and sigmoid colon. The procedure involves inserting the tube through the anus...
Sigmoidoscopy
Sigmoidoscopy is a diagnostic procedure that uses a flexible sigmoidoscope equipped with a light source and camera to examine the rectum and sigmoid colon. The procedure involves inserting the tube through the anus...
119
Oral Hypoglycemic Agents: Glinides
189
Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively...
189

